Northwest Biotherapeutics updates IPO

Northwest Biotherapeutics (Bothell, Wash.) amended its proposed IPO to raise $31.5-$38.5 million through the sale of 3.5 million shares at $9-$11. The company, which is developing dendritic cell-based...